C

Cartesian Therapeutics

25 employees

Pioneering Potent, Safer Cell Therapy in and Beyond Oncology

Basic info

Industry

biotechnology research

Sectors

Cardiovascular Disease
Biotechnology
Lung disease
multiple myeloma
Molecular Biology
Gene Therapy
Oncology
Cell Therapy
NETs
Immunology
Autoimmune Diseases
Immunotherapy
Cancer Research
ARDS
Myasthenia Gravis

Date founded

2016

Funding rounds raised

Total raised

$2M

from 2 investors over 2 rounds

C

Cartesian Therapeutics raised $2M on May 4, 2021

Investors: National Heart, Lung, and Blood Institute

C

Cartesian Therapeutics raised undisclosed on January 1, 2016

Investors: Schooner Capital

FAQ